XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2018
Mar. 31, 2018
Current Assets    
Cash and cash equivalents $ 186,681 $ 237,335
Accounts receivable 163
Bridge loan proceeds receivable 20,000
Warrant exercise proceeds receivable 9,860
Inventory 48,162 25,554
Employee advance 2,500 2,500
Prepaids 30,038 19,948
Total Current Assets 297,241 285,500
Property and Equipment:    
Property and equipment 145,863 122,682
Less: accumulated depreciation (110,086) (104,111)
Total Fixed Assets 35,777 18,571
Other Assets:    
Security deposit 8,201 10,200
Trademark and patents-net 844,193 1,253,510
Total Other Assets 852,394 1,263,710
Total Assets 1,185,412 1,567,781
Current Liabilities    
Accounts payable and accrued expenses 882,191 767,970
Accrued expenses - related party 461,776 559,884
Notes payable and accrued interest, net of debt discount 62,523
Notes payable and accrued interest - related party 91,193 103,279
Total Current Liabilities 1,497,683 1,431,133
Commitments and Contingencies
Stockholders' Equity (Deficit):    
Preferred stock, par value $0.001, 20,000,000 shares authorized 0 and 0 shares outstanding at December 31, 2018 and March 31, 2018, respectively
Common stock, par value $0.001, 250,000,000 shares authorized 20,543,088 and 18,279,075 shares outstanding at December 31, 2018 and March 31, 2018, respectively 20,543 18,279
Common stock to be issued 515,807 608,966
Treasury stock, 600,000 shares of common stock (177,600)
Additional Paid-In Capital 50,537,541 47,257,557
Accumulated Deficit (51,208,562) (47,748,154)
Total Stockholders' Equity (Deficit) (312,271) 136,648
Total Liabilities and Stockholders' Equity (Deficit) $ 1,185,412 $ 1,567,781